Surveillance of Antimicrobial Susceptibility Patterns among Shigella Species Isolated in China during the 7-Year Period of 2005-2011
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Shigella is a frequent cause of bacterial dysentery in the developing world. Treatment with antibiotics is recommended for shigellosis, but the options are limited due to globally emerging resistance. This study was conducted to determine the frequency and pattern of antimicrobial susceptibility of Shigella in China. Methods: We studied the antimicrobial resistance profiles of 308 Shigella spp. strains (260S. flexneri, 40 S. sonnei, 5 S. boydii, and 3 S. dysenteriae) isolated from fecal samples of patients (age, from 3 months to 92 yr) presenting with diarrhea in different districts of Anhui,China. The antimicrobial resistance of strains was determined by the agar dilution method according to the CSLI guidelines. Results: The most common serogroup in the Shigella isolates was S. flexneri (n=260, 84.4%),followed by S. sonnei (n=40, 13.0%). The highest resistance rate was found for nalidixic acid (96.4%), followed by ampicillin (93.2%), tetracycline (90.9%), and trimethoprim/sulfamethoxazole (80.8%). Among the isolates tested, 280 (91.0%) were multidrug resistant (resistant to ≥2 agents). The most common resistance pattern was the combination of ampicillin,tetracycline, and trimethoprim/sulfamethoxazole (70.8%). Resistance to ampicillin and tetracycline were more common among S. flexneri than among S. sonnei isolates. Conclusions: S. flexneri is predominant in Anhui, China, and its higher antimicrobial resistance rate compared with that of S. sonnei is a cause for concern. Continuous monitoring of resistance patterns is necessary to control the spread of resistance in Shigella. The recommendations for antimicrobial treatment must be updated regularly based on surveillance results.
Abstract
Background: Shigella is a frequent cause of bacterial dysentery in the developing world. Treatment with antibiotics is recommended for shigellosis, but the options are limited due to globally emerging resistance. This study was conducted to determine the frequency and pattern of antimicrobial susceptibility of Shigella in China. Methods: We studied the antimicrobial resistance profiles of 308 Shigella spp. strains (260S. flexneri, 40 S. sonnei, 5 S. boydii, and 3 S. dysenteriae) isolated from fecal samples of patients (age, from 3 months to 92 yr) presenting with diarrhea in different districts of Anhui,China. The antimicrobial resistance of strains was determined by the agar dilution method according to the CSLI guidelines. Results: The most common serogroup in the Shigella isolates was S. flexneri (n=260, 84.4%),followed by S. sonnei (n=40, 13.0%). The highest resistance rate was found for nalidixic acid (96.4%), followed by ampicillin (93.2%), tetracycline (90.9%), and trimethoprim/sulfamethoxazole (80.8%). Among the isolates tested, 280 (91.0%) were multidrug resistant (resistant to ≥2 agents). The most common resistance pattern was the combination of ampicillin,tetracycline, and trimethoprim/sulfamethoxazole (70.8%). Resistance to ampicillin and tetracycline were more common among S. flexneri than among S. sonnei isolates. Conclusions: S. flexneri is predominant in Anhui, China, and its higher antimicrobial resistance rate compared with that of S. sonnei is a cause for concern. Continuous monitoring of resistance patterns is necessary to control the spread of resistance in Shigella. The recommendations for antimicrobial treatment must be updated regularly based on surveillance results.
참고문헌 (19)
- Kotloff KL, "Global burden of Shigella infections: implications for vaccine development and implementation of control strategies", Bull World Health Organ, 77, pp.651~666 (1999)
- "Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1" (2005)[URL]
- Sur D, "Shigellosis: challenges & management issues", Indian J Med Res, 120, pp.454~462 (2004)
- Wang XY, "Trend and disease burden of bacillary dysentery in China (1991-2000)", Bull World Health Organ, 84, pp.561~568 (2006)
- Bhattacharya SK, "An evaluation of current shigellosis treatment", Expert Opin Pharmacother, 4, pp.1315~1320 (2003)
- Watanabe T, "Infective heredity of multiple drug resistance in bacteria", Bacteriol Rev, 27, pp.87~115 (1963)
- Sack RB, "Antimicrobial resistance in organisms causing diarrheal disease", Clin Infect Dis, 24, pp.S102~S105 (1997)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; Twenty-second Informational supplement, M100-S22" (2012), Clinical and Laboraotory Standards Institute
- Sivapalasingam S, "High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002", Antimicrob Agents Chemother, 50, pp.49~54 (2006)
- Ashkenazi S, "Recent trends in the epidemiology of Shigella species in Israel", Clin Infect Dis, 17, pp.897~899 (1993)
- DeLappe N, "Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infection", J Clin Microbiol, 41, pp.1919~1924 (2003)
- Ashkenazi S, "Growing antimicrobial resistance of Shigella isolates", J Antimicrob Chemother, 51, pp.427~429 (2003)
- von Seidlein L, "A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology", PLoS Med, 3, pp.e53~ (2006)
- Gu B, "Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009", Int J Antimicrob Agents, 40, pp.9~17 (2012)
- Xia S, "Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006", J Clin Microbiol, 49, pp.232~242 (2011)
- Pu XY, "Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China", J Antimicrob Chemother, 63, pp.917~920 (2009)
- Xiong Z, "Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China", J Antibiot (Tokyo), 63, pp.187~189 (2010)
- Keddy KH, "Systemic shigellosis in South Africa", Clin Infect Dis, 54, pp.1448~1454 (2012)
- Taneja N, "Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India", J Antimicrob Chemother, 67, pp.1347~1353 (2012)